Exploratory IND Is Planned Using GB Sciences’ Proprietary Mixtures of Botanical Compounds to Provide the Highest …

Sourcing sufficient quantities of these minor cannabinoids and terpenes is essential for providing the highest possible efficacy in GB Sciences’ PD formulations, but they are more difficult to procure in botanical form because they are in lower abundance in the cannabis plants. GB Sciences has been addressing these supply issues at its cultivation and extraction facility in Las Vegas, Nevada; however, currently there is only a sole source for domestic cannabis used in FDA research.

The challenge we have encountered in approaching the US FDA is that we may not be able to use cannabis-based materials that GB Sciences has developed in the US for our clinical trials,” explains Dr. Andrea Small-Howard, Chief Science Officer of GB Sciences. “We are committed to complying with all federal requirements, even though we believe we can implement a system for growing and extracting here that exceeds the quality and consistency of the

... read more at: https://www.prnewswire.com/news-releases/exploratory-ind-is-planned-using-gb-sciences-proprietary-mixtures-of-botanical-compounds-to-provide-the-highest-efficacy-for-patients-300630875.html

by